Several studies have reported reduced levels of APOE in the CSF of GBS patients, and it has been suggested that blood-brain barrier dysfunction, caused by APOE deficiency, may increase susceptibility to GBS and worsen the clinical symptoms of affected individuals (7). The gene discussed is APOE; the disease is hyperinsulinemic hypoglycemia, familial, 4.